Bayer AG (BAYN) Given a €140.00 Price Target at Baader Bank
Bayer AG (FRA:BAYN) has been given a €140.00 ($164.71) price objective by stock analysts at Baader Bank in a research note issued on Friday. The brokerage currently has a “buy” rating on the healthcare company’s stock.
Other equities analysts have also recently issued reports about the company. J P Morgan Chase & Co set a €125.00 ($147.06) price objective on Bayer AG and gave the company a “buy” rating in a report on Monday, July 3rd. UBS AG set a €125.00 ($147.06) price target on Bayer AG and gave the stock a “buy” rating in a research note on Monday, July 3rd. BNP Paribas set a €103.00 ($121.18) price target on Bayer AG and gave the stock a “neutral” rating in a research note on Monday, July 3rd. Deutsche Bank AG set a €124.00 ($145.88) price target on Bayer AG and gave the stock a “buy” rating in a research note on Monday, July 24th. Finally, Independent Research GmbH set a €120.00 ($141.18) price target on Bayer AG and gave the stock a “neutral” rating in a research note on Monday, July 3rd. Eight equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Bayer AG has a consensus rating of “Buy” and an average target price of €122.23 ($143.80).
Bayer AG (FRA BAYN) opened at 118.525 on Friday. Bayer AG has a 52 week low of €85.72 and a 52 week high of €123.83. The firm has a market cap of €103.37 billion and a P/E ratio of 20.503. The firm’s 50-day moving average price is €112.83 and its 200 day moving average price is €112.63.
TRADEMARK VIOLATION WARNING: This story was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this story on another domain, it was illegally copied and republished in violation of United States and international copyright & trademark law. The legal version of this story can be accessed at https://www.thecerbatgem.com/2017/10/20/bayer-ag-bayn-given-a-140-00-price-target-at-baader-bank-2.html.
About Bayer AG
Receive News & Stock Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related stocks with our FREE daily email newsletter.